nature.com search

Loading Filters

Showing 1–20 of 20 results

Loading Filters

Research | 14 July 2013
Attributing the increase in atmospheric CO₂ to emitters and absorbers
- S J Mehta School of Management, Indian...
- P. Ciais
- , T. Gasser
- , J. D. Paris
- , K. Caldeira
- , M. R. Raupach
- , J. G. Canadell
- , A. Patwardhan
- , P. Friedlingstein
- , S. L. Piao
- & V. Gitz
Nature Climate Change 3 , 926–930

Rights & permissionsfor article Attributing the increase in atmospheric CO<sub>2</sub> to emitters and absorbers . Opens in a new window.
Research | 5 June 2006
Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
- j-mehta@northwestern.edu
- J Mehta
- , L I Gordon
- , M S Tallman
- , J N Winter
- , A O Evens
- , O Frankfurt
- , S F Williams
- , D Grinblatt
- , L Kaminer
- , R Meagher
- & S Singhal
Bone Marrow Transplantation 38 , 95–100

Rights & permissionsfor article Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially? . Opens in a new window.
Research | 12 April 2004
High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission
- j-mehta@northwestern.edu
- J Mehta
- , R Powles
- , B Sirohi
- , J Treleaven
- , S Kulkarni
- & S Singhal
Bone Marrow Transplantation 33 , 1107–1114

Rights & permissionsfor article High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission . Opens in a new window.
Research | 25 June 2007
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole
- j-mehta@northwestern.edu
- S Trifilio
- , S Singhal
- , S Williams
- , O Frankfurt
- , L Gordon
- , A Evens
- , J Winter
- , M Tallman
- , J Pi
- & J Mehta
Bone Marrow Transplantation 40 , 451–456

Rights & permissionsfor article Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole . Opens in a new window.
Research | 26 January 2004
How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients?
- j-mehta@northwestern.edu
- A Verma
- , J Pedicano
- , S Trifilio
- , S Singhal
- , M Tallman
- , J Winter
- , S Williams
- , L Gordon
- , J Monreal
- & J Mehta
Bone Marrow Transplantation 33 , 715–719

Rights & permissionsfor article How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients? . Opens in a new window.
Research | 6 September 2010
Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies
- j-mehta@northwestern.edu
- S M Trifilio
- , J Pi
- , J Zook
- , M Golf
- , K Coyle
- , D Greenberg
- , D Newman
- , M Koslosky
- & J Mehta
Bone Marrow Transplantation 46 , 800–805

Rights & permissionsfor article Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies . Opens in a new window.
Research | 7 July 2008
Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: what should the threshold required for apheresis be?
- j-mehta@northwestern.edu
- A Gidron
- , V Singh
- , K Egan
- & J Mehta
Bone Marrow Transplantation 42 , 439–442

Rights & permissionsfor article Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: what should the threshold required for apheresis be? . Opens in a new window.
Research | 12 January 2004
Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients
- j-mehta@northwestern.edu
- J Mehta
- , S Singhal
- , A P Gee
- , K-Y Chiang
- , K Godder
- , F van Rhee
- , S DeRienzo
- , W O'Neal
- , L Lamb
- & P J Henslee-Downey
Bone Marrow Transplantation 33 , 389–396

Rights & permissionsfor article Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients . Opens in a new window.
Research | 7 December 2009
Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring
- j-mehta@northwestern.edu
- S M Trifilio
- , M H Scheetz
- , J Pi
- & J Mehta
Bone Marrow Transplantation 45 , 1352–1356

Rights & permissionsfor article Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring . Opens in a new window.
Research | 17 May 2006
Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia
- j-mehta@northwestern.edu
- S Trifilio
- , L Gordon
- , S Singhal
- , M Tallman
- , A Evens
- , K Rashid
- , M Fishman
- , K Masino
- , J Pi
- & J Mehta
Bone Marrow Transplantation 37 , 997–1001

Rights & permissionsfor article Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia . Opens in a new window.
Research | 10 September 2007
Correlation between serum lactate dehydrogenase and stem cell mobilization
- j-mehta@northwestern.edu
- K Egan
- , V Singh
- , A Gidron
- & J Mehta
Bone Marrow Transplantation 40 , 931–934

Rights & permissionsfor article Correlation between serum lactate dehydrogenase and stem cell mobilization . Opens in a new window.
Research | 17 January 2005
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
- j-mehta@northwestern.edu
- S Trifilio
- , R Ortiz
- , G Pennick
- , A Verma
- , J Pi
- , V Stosor
- , T Zembower
- & J Mehta
Bone Marrow Transplantation 35 , 509–513

Rights & permissionsfor article Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients . Opens in a new window.
Research | 6 October 2008
Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?
- j-mehta@northwestern.edu
- V Singh
- , J Krishnamurthy
- , S Duffey
- , R Meagher
- , M Villa
- , J Monreal
- , A Evens
- , O Frankfurt
- , J Altman
- , L Gordon
- , M Tallman
- , S Williams
- , J Winter
- , S Singhal
- & J Mehta
Bone Marrow Transplantation 43 , 301–305

Rights & permissionsfor article Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma? . Opens in a new window.
Research | 6 December 2004
Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?
- j-mehta@northwestern.edu
- A Gidron
- , A Verma
- , M Doyle
- , L Boggio
- , A Evens
- , L Gordon
- , S Singhal
- , M Tallman
- , S Williams
- , J Winter
- & J Mehta
Bone Marrow Transplantation 35 , 243–246

Rights & permissionsfor article Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies? . Opens in a new window.
Research | 14 April 2008
The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients
- j-mehta@northwestern.edu
- B Sirohi
- , R Powles
- , J Treleaven
- , S Kulkarni
- , R Saso
- , M Potter
- , M Ethell
- , G Morgan
- , S Singhal
- & J Mehta
Bone Marrow Transplantation 42 , 105–112

Rights & permissionsfor article The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients . Opens in a new window.
Research | 1 August 2005
Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF
- j-mehta@northwestern.edu
- M Tomblyn
- , L I Gordon
- , S Singhal
- , M S Tallman
- , S Williams
- , J N Winter
- , A Evens
- & J Mehta
Bone Marrow Transplantation 36 , 663–666

Rights & permissionsfor article Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF . Opens in a new window.
Research | 1 December 2003
Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation?
- j-mehta@northwestern.edu
- J Cilley
- , C Rihn
- , J Monreal
- , L I Gordon
- , S Singhal
- , M Tallman
- , S Williams
- , J Winter
- & J Mehta
Bone Marrow Transplantation 33 , 161–164

Rights & permissionsfor article Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation? . Opens in a new window.
Reviews | 13 August 2008
Current status of autologous hematopoietic stem cell transplantation in myeloma
- j-mehta@northwestern.edu
- J Mehta
- & S Singhal
Bone Marrow Transplantation 42 , S28–S34

Rights & permissionsfor article Current status of autologous hematopoietic stem cell transplantation in myeloma . Opens in a new window.
Correspondence | 8 January 2007
Rigorous administration of methotrexate and outcome of allogeneic blood stem cell transplantation
- j-mehta@northwestern.edu
- J Mehta
- & S Singhal
Bone Marrow Transplantation 39 , 243–244

Rights & permissionsfor article Rigorous administration of methotrexate and outcome of allogeneic blood stem cell transplantation . Opens in a new window.
Reviews | 6 August 2007
High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years
- j-mehta@northwestern.edu
- J Mehta
- & S Singhal
Bone Marrow Transplantation 40 , 1101–1114

Rights & permissionsfor article High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years . Opens in a new window.

Refine your results by…

Filters

Filter By:

Attributing the increase in atmospheric CO₂ to emitters and absorbers

Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?

High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission

Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole

How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients?

Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies

Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: what should the threshold required for apheresis be?

Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients

Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring

Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia

Correlation between serum lactate dehydrogenase and stem cell mobilization

Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients

Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?

Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?

The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients

Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF

Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation?

Current status of autologous hematopoietic stem cell transplantation in myeloma

Rigorous administration of methotrexate and outcome of allogeneic blood stem cell transplantation

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters